ASTRASINOL
LIVE

Serial Number

79383363

Owner

EXSYMOL

Attorney

Ted Houlehan

Filing Date

Sep 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ASTRASINOL Trademark

Serial Number: 79383363 • Registration: 7498021

ASTRASINOL is a trademark filed by EXSYMOL on September 15, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning). The application is currently registered and active.

Owner Contact Info

EXSYMOL (9 trademarks)

4, avenue Albert II

Entity Type: 99

Trademark Details

Filing Date

September 15, 2023

Registration Date

September 10, 2024

Published for Opposition

June 25, 2024

Goods & Services

Cosmetics and cosmetic preparations

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 10, 2026 COAR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 15, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 10, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 10, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 28, 2024 GPNX
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 13, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2024 OP2R
NOTICE OF PUBLICATION
Jun 5, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
ASSIGNED TO EXAMINER
May 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 24, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 17, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 16, 2023 REPR